Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEpe Special Opp Regulatory News (ESO)

Share Price Information for Epe Special Opp (ESO)

Share Price is delayed by 15 minutes
Get Live Data
237.00    -1.00 (-0.42%)
Bid:
232.00
Ask:
242.00
Spread: 10.00 (4.31%)
Market Cap: £58.41m
ESO Live PriceLast checked at - London Stock Exchange

Intraday Epe Special Opp Share Chart

Investment

4 Jul 2025 10:00

RNS Number : 8005P
EPE Special Opportunities Limited
04 July 2025
 

EPE Special Opportunities Limited

 

Investment

 

 

EPE Special Opportunities Limited ("ESO" or the "Company") is pleased to announce that on 2 July 2025, ESO Investments 1 Limited (an undertaking of ESO, in which it is the sole investor) ("ESO 1") acquired a majority stake in Prism Holdco (2025) Limited (the "Target" or, together with undertakings, the "Target Group") (the "Transaction").

 

The Target Group owns the LSA International brand which designs, develops and distributes a wide range of award-winning interior products, including glassware, tableware and interior accessories. The Target Group has achieved a strong reputation for design led, contemporary products centred on quality, craftmanship and sustainability. The Target Group supplies a broad range of premium retailers, hospitality partners and distributors in the UK and international markets, as well as operating e-commerce and marketplace channels. ESO will assist the Target Group's future growth ambitions, accelerated by collaboration and integration with the Company's existing portfolio company in the sector, the Rayware Group.

 

As part of the transaction, ESO 1 is investing up to £2.1 million (funded by cash reserves advanced from ESO) to fund the paydown of bank debt (£1.1 million) and to support working capital (£1.0 million), and ESO issued 298,013 shares to the former shareholders of LSA International. Following the Transaction, ESO has available cash of £7.1 million. The Transaction has no impact on the Company's net asset value.

 

Application has been made for the admission to trading on AIM of the 298,013 consideration shares which is expected to occur on 9 July 2025. Following admission, ESO will have 28,396,073 ordinary shares in issue with each ordinary share carrying the right to one vote. The total number of voting rights in the Company is therefore 28,396,073. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interests in, the Company under the FCA's Disclosure and Transparency Rules.

 

About ESO

 

· ESO is an AIM-quoted, private equity investment company, whose objective is to provide long-term return on equity for its shareholders by investing in SMEs.

 

· ESO seeks to invest up to £30 million into companies with strong fundamentals, including defensible competitive positioning and high levels of cash generation, and aims to partner with outstanding management teams to combine operational and financial expertise in each investment.

 

· ESO will consider most industry sectors, including consumer, retail, manufacturing, financial services and the broader services sectors, and can make direct investments, special situations investments, primary and secondary fund investments and private investments in public equities.

 

· ESO's investment horizon is flexible, creating the opportunity to maximise value via optimising exit timing, compounding returns and re-investing behind successful management teams.

 

The person responsible for releasing this information on behalf of the Company is Amanda Robinson of Langham Hall Fund Management (Jersey) Limited.

 

Enquiries:

 

EPIC Investment Partners LLP

+44 (0) 207 269 8860

Rupert Palmer

Langham Hall Fund Management (Jersey) Limited

+44 (0) 153 488 5200

Amanda Robinson

 

Cardew Group Limited

+44 (0) 207 930 0777

Richard Spiegelberg

 

Deutsche Numis

+44 (0) 207 260 1000

Nominated Advisor:

Stuart Skinner / Emma Brown

Corporate Broker:

Charles Farquhar

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQRIMPTMTIMMFA
Date   Source Headline
28th Sep 20187:00 amRNSInterim Review and Unaudited Financial Statements
21st Sep 20187:00 amRNSRe-admission to AIM and NEX Exchange Growth Market
20th Sep 20187:00 amRNSCompany ISIN
13th Sep 20187:30 amRNSSuspension - EPE Special Opportunities Plc
13th Sep 20187:00 amRNSCompletion of Migration and Suspension of Shares
24th Aug 201812:33 pmRNSResult of Meeting
3rd Aug 20187:00 amRNSAcquisition of shares in Luceco plc
1st Aug 20188:00 amRNSSchedule 1 - EPE Special Opportunities plc
1st Aug 20187:01 amRNSMigration to Bermuda - Publication of Circular
1st Aug 20187:00 amRNSMigration to Burmuda - Readmission to NEX Exchange
31st Jul 20186:00 pmRNSCompletion of Unsecured Loan Notes Redemption
25th Jul 201811:23 amRNSResult of AGM
9th Jul 20183:22 pmRNSNet Asset Value(s)
28th Jun 20187:00 amRNSRedemption of Unsecured Loan Notes
26th Jun 20187:00 amRNSNotice of AGM
8th Jun 201811:54 amRNSNet Asset Value(s)
2nd May 20187:00 amRNSAnnual Financial Report
29th Mar 20187:00 amRNSPortfolio Update
6th Mar 20188:59 amRNSUpdate Regarding Luceco plc and Share Buybacks
4th Jan 20189:30 amRNSAnnouncement of Share Buy Backs
4th Jan 20188:44 amRNSAnnouncement of Share Buy Backs
2nd Jan 20184:36 pmRNSPrice Monitoring Extension
19th Dec 20177:00 amRNSInvestment
15th Dec 201712:19 pmRNSNet Asset Value(s)
7th Nov 20174:55 pmRNSNet Asset Value(s)
9th Oct 20171:59 pmRNSNet Asset Value
11th Sep 20177:13 amRNSInterim Review and Unaudited Financial Statements
9th Aug 20177:00 amRNSVesting - Share Matching Scheme/PDMR Shareholdings
7th Aug 20173:24 pmRNSExercise of Warrants and Issue of Shares
31st Jul 201711:11 amRNSAmendment of warrant exercise date
26th Jul 20171:29 pmRNSTransaction in Own Shares & PDMR Shareholding
26th Jul 20171:25 pmRNSResult of AGM
7th Jul 201712:19 pmRNSNet Asset Value(s)
9th Jun 20172:46 pmRNSTransaction in Own Shares
8th Jun 20179:22 amRNSTransaction in Own Shares
7th Jun 20175:17 pmRNSNet Asset Value(s)
7th Jun 201710:00 amRNSTransaction in Own Shares
6th Jun 201710:51 amRNSTransaction in Own Shares
2nd Jun 20173:12 pmRNSTransaction in Own Shares
1st Jun 20175:22 pmRNSTransaction in Own Shares
31st May 20175:38 pmRNSTransaction in Own Shares
30th May 20175:53 pmRNSTransaction in Own Shares
23rd May 20178:43 amRNSNet Asset Value(s)
22nd May 20177:00 amRNSAGM Notice And Operations Move
11th May 20173:16 pmRNSPosting of Annual Report and Accounts
5th May 20175:36 pmRNSBlock listing Interim Review
26th Apr 20178:35 amRNSTransaction in Own Shares
21st Apr 20176:16 pmRNSTransaction in Own Shares
3rd Apr 20177:15 amRNSAnnual Financial Report
10th Feb 20178:39 amRNSAppointment of Non-Executive Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.